iBio, Inc. (IBIO) – Management Comments
-
iBio, Inc. (IBIO) Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate
-
iBio, Inc. (IBIO) Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to IBIO Stock Lookup